Cargando…
Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
Psoriasis is an immune-mediated inflammatory disease, with a chronic relapsing-remitting course, which affects 2–3% of the worldwide population. The progressive acquisitions of the inflammatory pathways involved in the development of psoriasis have led to the identification of the key molecules of t...
Autores principales: | Campanati, Anna, Marani, Andrea, Martina, Emanuela, Diotallevi, Federico, Radi, Giulia, Offidani, Annamaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615182/ https://www.ncbi.nlm.nih.gov/pubmed/34829740 http://dx.doi.org/10.3390/biomedicines9111511 |
Ejemplares similares
-
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities
por: Campanati, Anna, et al.
Publicado: (2022) -
Saliva Proteomics as Fluid Signature of Inflammatory and Immune-Mediated Skin Diseases
por: Campanati, Anna, et al.
Publicado: (2021) -
Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review
por: Martina, Emanuela, et al.
Publicado: (2021) -
The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review
por: Diotallevi, Federico, et al.
Publicado: (2022) -
Mesenchymal Stem Cells and Psoriasis: Systematic Review
por: Diotallevi, Federico, et al.
Publicado: (2022)